Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02870868 · ClinicalTrials.gov registry record · NA
Breathing Interventions for Relaxation: Dosing Through Extended Exhale
A NA study of Stress and Healthy Adults, sponsored by Vanderbilt University Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 99
- Enrollment target
- 1
- Study location
NCT02870868: Completed NA study of Stress and Healthy Adults, sponsored by Vanderbilt University Medical Center.
NCT02870868 is a NA study of Stress and Healthy Adults that has completed, run by Vanderbilt University Medical Center. The registered enrollment target is 99 participants, below the 785-participant average among 152 other Stress trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02870868, a NA study of Stress and Healthy Adults, has completed, sponsored by Vanderbilt University Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 99 participants
- Enrollment target
- 1
- Study location
Study Summary
Breathing exercises are categorized as a mind-body practice. One in ten adults in the U.S. use breathing exercises for health purposes. The aim of this project is to examine if different slow breathing has different physiological and psychological effects.
Primary Outcome
This is a proxy measure of parasympathetic tone. In normal healthy adults, the average value is around 600 ms\^2 (miliseconds\*miliseconds). In hypertensive adults, the average value is around 100 ms\^2. In patients with autonomic failure (who lacks parasympathetic tone), the average value is around 20 ms\^2.
Conditions Studied
Interventions
- BEHAVIORAL Slow breathing
Study Locations (1)
Tennessee
- Vanderbilt University Medical Center - Nashville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 99 participants |
| Start Date | 2016-10-14 |
| Est. Completion | 2018-12-19 |
| Phase | NA |
What the finished NCT02870868 record still lists
NCT02870868 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 99 participants, a relatively small participant target, below the 785-participant average among 152 other Stress trials with a reported enrollment target (87% lower).
The record links to 2 conditions, with Stress appearing as the primary indexed condition, and to 1 intervention - of which Slow breathing is the first listed.
NCT02870868 reports a single indexed study location in Tennessee.
Frequently Asked Questions
What is clinical trial NCT02870868 about?
NCT02870868 is a clinical study titled "Breathing Interventions for Relaxation: Dosing Through Extended Exhale". Breathing exercises are categorized as a mind-body practice. One in ten adults in the U.S. use breathing exercises for health purposes. The aim of this project is to examine if different slow breathing has different physiological and psychological effects.
What is the current status of trial NCT02870868?
This trial is currently completed. It is a NA study. The enrollment target is 99 participants. The study started on 2016-10-14. Estimated completion is 2018-12-19.
What conditions does trial NCT02870868 study?
This clinical trial studies the following conditions: Stress, Healthy Adults.
What interventions are being tested in trial NCT02870868?
The interventions under investigation include: Slow breathing (BEHAVIORAL).
Who is sponsoring clinical trial NCT02870868?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02870868 being conducted?
This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stress
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02870868's enrollment target sits among peer trials
99 68th of 152 higher than 85 of 152 other Stress trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Stress trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Mindfulness-Based Intervention With a Supplement for Stress-Related Problems in College Students Across Multiple Sites (4SITE)
RECRUITING · NA
-
Digital Intervention for Physical Activity
RECRUITING · NA
-
Cocooned Moms Study
RECRUITING · NA
-
Student Exercise and Sleep Timing Study - Part 2
RECRUITING · NA
-
Smartphone-based Cognitive Emotion Regulation Training for Unpaid Primary Caregivers of Persons With Alzheimer's Disease
RECRUITING · NA
-
ACT for HIV-Positive Men
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03965234 · 99 participants · Phase 1
Pulmonary Suffusion in Controlling Minimal Residual Disease in Patients With Sarcoma or Colorectal Metastases
- NCT04022616 · 99 participants
Myeloid-Derived Suppressor Cell Function in Breast Cancer Patients
- NCT04042844 · 99 participants · Phase 2
A Single Dose of BRTX 100 for Patients With Chronic Lumbar Disc Disease (cLDD)
- NCT04143724 · 99 participants · Phase 2
Study of Safety & PK of Luspatercept (ACE-536) in Pediatric Participants With Beta (β)-Thalassemia
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI